Several studies, including ours, reported that weight loss through calorie restriction or the SGLT2 inhibitor dapagliflozin can induce a significant reduction in serum sDPP-4/CD26 in people with type 2 diabetes.21 The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.